| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.66▼ | 2.67▼ | 2.68▼ | 2.89▼ | 3.19▼ |
| MA10 | 2.67▼ | 2.70▼ | 2.84▼ | 3.15▼ | 3.47▼ |
| MA20 | 2.73▼ | 2.84▼ | 2.93▼ | 3.17▼ | 3.58▼ |
| MA50 | 2.89▼ | 3.00▼ | 3.18▼ | 3.35▼ | 3.24▼ |
| MA100 | 3.00▼ | 3.19▼ | 3.18▼ | 3.58▼ | 3.90▼ |
| MA200 | 3.20▼ | 3.22▼ | 3.42▼ | 3.39▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.013▼ | -0.028▼ | -0.054▼ | -0.097▼ |
| RSI | 31.714▼ | 31.435▼ | 34.189▼ | 36.478▼ | 43.265▼ |
| STOCH | 8.333▼ | 1.858▼ | 7.793▼ | 21.504 | 22.439 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -96.979▼ | -98.425▼ |
| CCI | -189.459▼ | -69.483 | -117.167▼ | -181.938▼ | -110.121▼ |
|
Thursday, June 05, 2025 04:59 PM
June 06, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene ...
|
|
Thursday, May 01, 2025 05:00 PM
The latest price target for Senti Biosciences (NASDAQ:SNTI) was reported by Laidlaw & Co. on June 6, 2025. The analyst firm set a price target for $15.00 expecting SNTI to rise to within 12 months ...
|
|
Wednesday, April 16, 2025 06:15 AM
Morningstar brands and products Company Portfolio ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 2.89 | 2.95 | 2.56 | 2.60 | 94,600 |
| 12/06/25 | 3.035 | 3.0958 | 2.7863 | 2.86 | 102,778 |
| 11/06/25 | 3.20 | 3.20 | 2.78 | 2.81 | 183,797 |
| 10/06/25 | 3.11 | 3.33 | 3.045 | 3.05 | 124,517 |
| 09/06/25 | 3.65 | 3.70 | 2.99 | 3.12 | 287,663 |
| 06/06/25 | 3.57 | 3.884 | 3.30 | 3.84 | 67,600 |
| 05/06/25 | 3.247 | 3.62 | 3.24 | 3.56 | 24,000 |
| 04/06/25 | 3.2007 | 3.43 | 3.07 | 3.39 | 27,060 |
| 03/06/25 | 3.18 | 3.2091 | 3.04 | 3.15 | 20,345 |
| 02/06/25 | 3.15 | 3.25 | 3.09 | 3.09 | 13,800 |
|
|
||||
|
|
||||
|
|